Department of Infectious Diseases, Molecular Virology, Heidelberg University, 69120 Heidelberg, Germany.
Department of Infectious Diseases, Molecular Virology, Heidelberg University, 69120 Heidelberg, Germany; Center for Infection Research (DZIF), Partner Site Heidelberg, 69120 Heidelberg, Germany.
Cell Rep. 2021 Nov 23;37(8):110049. doi: 10.1016/j.celrep.2021.110049. Epub 2021 Nov 10.
Positive-strand RNA viruses replicate in close association with rearranged intracellular membranes. For hepatitis C virus (HCV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), these rearrangements comprise endoplasmic reticulum (ER)-derived double membrane vesicles (DMVs) serving as RNA replication sites. Cellular factors involved in DMV biogenesis are poorly defined. Here, we show that despite structural similarity of viral DMVs with autophagosomes, conventional macroautophagy is dispensable for HCV and SARS-CoV-2 replication. However, both viruses exploit factors involved in autophagosome formation, most notably class III phosphatidylinositol 3-kinase (PI3K). As revealed with a biosensor, PI3K is activated in cells infected with either virus to produce phosphatidylinositol 3-phosphate (PI3P) while kinase complex inhibition or depletion profoundly reduces replication and viral DMV formation. The PI3P-binding protein DFCP1, recruited to omegasomes in early steps of autophagosome formation, participates in replication and DMV formation of both viruses. These results indicate that phylogenetically unrelated HCV and SARS-CoV-2 exploit similar components of the autophagy machinery to create their replication organelles.
正链 RNA 病毒在与重新排列的细胞内膜密切相关的情况下进行复制。对于丙型肝炎病毒 (HCV) 和严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2),这些重排包括内质网 (ER) 衍生的双层膜囊泡 (DMV),作为 RNA 复制位点。参与 DMV 生物发生的细胞因子定义不明确。在这里,我们表明,尽管病毒 DMV 与自噬体在结构上相似,但常规的巨自噬对于 HCV 和 SARS-CoV-2 的复制是可有可无的。然而,这两种病毒都利用参与自噬体形成的因素,特别是 III 类磷酸肌醇 3-激酶 (PI3K)。正如生物传感器所揭示的,PI3K 在受任一病毒感染的细胞中被激活,以产生磷脂酰肌醇 3-磷酸 (PI3P),而激酶复合物的抑制或耗竭则严重降低了复制和病毒 DMV 的形成。PI3P 结合蛋白 DFCP1 在自噬体形成的早期步骤中被招募到 omegasomes,参与两种病毒的复制和 DMV 的形成。这些结果表明,系统发育上无关的 HCV 和 SARS-CoV-2 利用相似的自噬机制成分来创建它们的复制细胞器。